Study Title
Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and beta-Amyloid in Normal Adults
Journal of the American Medical Association

Mark A. Fishel, MD; G. Stennis Watson, PhD; Thomas J. Montine, MD, PhD; Qin Wang, PhD; Pattie S. Green, PhD; J. Jacob Kulstad, BS; David G. Cook, PhD; Elaine R. Peskind, MD; Laura D. Baker, PhD; Dmitry Goldgaber, PhD; Wei Nie, MD, PhD; Sanjay Asthana, MD;


Background: Inflammation has been implicated as a pathogenetic factor in Alzheimer disease, possibly via effects on beta-amyloid. Hyperinsulinemia induces inflammation and is a risk factor for Alzheimer disease. Thus, insulin abnormalities may contribute to Alzheimer disease pathophysiology through effects on the inflammatory network.
Objectives: To determine the effects of induced hyperinsulinemia with euglycemia on beta-amyloid, transthyretin, and inflammatory markers and modulators in plasma and cerebrospinal fluid (CSF).
Design: Randomized crossover trial. Setting: Veterans Affairs hospital clinical research unit.
Participants: Sixteen healthy adults ranging from 55 to 81 years of age (mean age, 68.2 years).
Interventions: On separate mornings, fasting participants received randomized infusions of saline or insulin (1.0 mU · kg-1 · min-1) with variable dextrose levels to maintain euglycemia, achieving plasma insulin levels typical of insulin resistance. Plasma and CSF were collected after an approximately 105-minute infusion.
Main Outcome Measures: Plasma and CSF levels of interleukin 1 alpha, interleukin 1 beta, interleukin 6, tumor necrosis factor alpha, F2-isoprostane (CSF only), beta-amyloid, norepinephrine, transthyretin, and apolipoprotein E.
Results: Insulin increased CSF levels of F2-isoprostane and cytokines (both P

October 1, 2005
View study

Share This

Related Topics

InflammationAlzheimer’sInsulin Resistance

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD